Elucidation of the in vitro antitumor effects of Pleurotus ostreatus polysaccharides is very important for their future clinical application. In this paper, we use Sarcoma-180 (S180) cells to test the antitumor activity of the mushroom polysaccharides. The S180 cells in freshly prepared mouse ascites were directly treated by water-soluble polysaccharides from mycelium of Pleurotus ostreatus and immediately detected by MTT [3-(4,5)-dimethylthiahiazo (-z-y1)-3,5-di- phenytetrazoliumromide] method. The results can be directly visualized with naked eyes through the color changes. The in vitro antitumor activity of P. ostreatus polysaccharides on S180 cells are dose-dependently and time-dependently. P. ostreatus strains p11, p23, P44, p105 and p176 showed significant inhibition to S180 cell activity under high polysaccharides concentration (1000μg/ml ~ 1250μg/ml), and there are non-significant effects under the middle concentration (750μg/ml). On the contrary, the S180 cell activity were significantly enhanced under low concentration (250μg/mL-500μg/ml). The effects of polysaccharides generally increased during 4-8 treat hours, but remained stable more than 7 hours. However, the strains P23, P44 and P105 enhanced the S180 cell activity for short time processing (4-5h), but inhibited the cell activity for long time processing (6-8h). Among the tested mushroom strains, P44 exhibited the highest inhibition rate (68.4%) under high concentration of 1250µg/ml and treat time of 7-8 hours, P23 had the highest enhancement (119.5%) under low concentration of 250µg/ml and treat time of 8 hours. The antitumor activity of P. ostreatus polysaccharides was dependent on its concentration and treat time, indicating the complicated antitumor mechanism of mushroom polysaccharides and the strict study should be conducted before their clinical application.
Published in | American Journal of BioScience (Volume 10, Issue 2) |
DOI | 10.11648/j.ajbio.20221002.16 |
Page(s) | 75-80 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2022. Published by Science Publishing Group |
Pleurotus ostreatus, Polysaccharides, MTT, S180 Cell, Antitumor Activity
[1] | Borchers A. T., Keen C. L. and Gershwin M. E. (2004). Mushrooms, tumors, and immunity: an update. Experimental Biology and Medicine, 229 (5): 393-406. |
[2] | He Yanli, Zhang Lijuan and Wang Hua (2019). The biological activities of the antitumor drug Grifola frondosa polysaccharide. Progress in Molecular Biology and Translational Science, 163: 221-261. |
[3] | Mishra Vartika, Tomar Sarika, Yadav Priyanka and Singh, M. P. (2021). Promising anticancer activity of polysaccharides and other macromolecules derived from oyster mushroom (Pleurotus sp.): An updated review. International Journal of Biological Macromolecules, 182: 1628-1637. |
[4] | Bradner W. T., Clarke D. A. and Stock C. C. (1958). Stimulation of host defense against experimental cancer. I. Zymosan and Sarcoma 180 in mice. Cancer Research, 18: 347-351. |
[5] | Lindequist U., Niedermeyer T. H. J. and Wolf-Dieter J. (2005). The pharmacological potential of mushrooms. Evidence-based complementary and alternative medicine: eCAM, 2: 285-299. |
[6] | Faten Hereher, Amira ElFalla, Elshahat Toson, Mohammed Abou-Dobara and Mohamed Abdelaziz (2018). Pilot study: Tumor suppressive effect of crude polysaccharide substances extracted from some selected mushroom. Beni-Suef University Journal of Basic and Applied Sciences, 7 (4): 767-775. |
[7] | Sun L. X., Lin Z. B., Duan X. S., Lu J., Ge Z. H. and Li X. F. et al. (2012). Enhanced MHC class I and costimulatory molecules on B16F10 cells by Ganoderma lucidum polysaccharides. Journal of Drug Targeting, 20 (7): 582-92. |
[8] | Elisashvili V. (2012). Submerged cultivation of medicinal mushrooms: bioprocesses and products (review). International Journal of Medicinal Mushrooms, 14 (3): 211-239. |
[9] | Wasser S. P. (2011). Current findings, future trends, and unsolved problems in studies of medicinal mushrooms. Applied microbiology and biotechnology, 89 (5): 1323-1332. |
[10] | Li Weiyong, Wang Jinglin, Hu Huiping, Li Qiang, Liu Ying and Wang Kaiping (2018). Functional polysaccharide Lentinan suppresses human breast cancer growth via inducing autophagy and caspase-7-mediated apoptosis. Journal of Functional Foods, 45: 75-85. |
[11] | Zhang Yunshan, Zhang Zhuomin, Liu Hui, Wang De, Wang Jiahui and Deng Zhiwei et al. (2020). Physicochemical characterization and antitumor activity in vitro of a selenium polysaccharide from Pleurotus ostreatus. International Journal of Biological Macromolecules, 165: 2934-2946. |
[12] | El-Deeb Nehal M., El-Adawi Hala I., El-Wahab Abeer E. Abd, Haddad Ahmed M., El Enshasy Hesham A., and He You-Wen et al. (2019). Modulation of NKG2D, KIR2DL and cytokine production by Pleurotus ostreatus glucan enhances natural killer cell cytotoxicity toward cancer cells. Frontiers in Cell and Developmental Biology, 7: 165. |
[13] | Youn Jeong Cha, Nuhu Alam, Jae Seong Lee, Kyung Rim Lee, Mi Ja Shim and Min Woong Lee et al. (2018). Anticancer and immunopotentiating activities of crude polysaccharides from Pleurotus nebrodensis on mouse sarcoma 180. Mycobiology, 40 (4): 236-243. |
[14] | Silva S., Martins S., Karmali A. and Rosa E. (2012). Production, purification and characterisation of polysaccharides from Pleurotus ostreatus with antitumour activity. Journal of the science of food and agriculture, 92 (9): 1826-1832. |
[15] | Inagaki N., Shibata T., Itoh T., Suzuki T., Tanaka H. and Nakamura, T. et al. (2005). Inhibition of IgE-dependent mouse triphasic cutaneous reaction by a boiling water fraction separated from mycelium of Phellinus linteus. Evidence-based complementary and alternative medicine: eCAM, 2: 369-374. |
[16] | Chihara G., Hamuro J., Maeda Y. Y., Arai Y. and Fukuoka F. (1970). Fractionation and purification of the polysaccharides with marked antitumor activity, especially lentinan, from Lentinus edodes (Berk.) Sing, (an Edible Mushroom). Cancer Research, 30: 2776-2781. |
[17] | Fotakis G. and Timbrell J. A. (2006). In vitro cytotoxicity assays: Comparison of LDH, neutral red, MTT and protein assay in hepatoma cell lines following exposure to cadmiµm chloride. Toxicology Letters, 7 (1): 171-177. |
[18] | Nesrin M. Morsy, Ashraf S. Hassan, Taghrid S. Hafez, Mohamed R. H. Mahran, Inass A. Sadawe and Abdul M. Gbaj (2020). Synthesis, antitumor activity, enzyme assay, DNA binding and molecular docking of Bis-Schiff bases of pyrazoles. Journal of the Iranian Chemical Society, 18: 1-13. |
[19] | Gao Wenwen, Wang Wangdi, Sun Wenjian, Wang Mingfang, Zhang Na and Yu Shuwen (2017). Antitumor and immunomodulating activities of six Phellinus igniarius polysaccharides of different origins. Experimental and Therapeutic Medicine, 14 (5): 4627-4632. |
[20] | Qiu S., Huang S., Huang J., Pan J. and Zhang W. (2010). Antitumor activity of the water-soluble polysaccharide from Hyriopsis cumingii in vitro. Toxicology and Industrial Health, 26: 151-161. |
[21] | Lu D., Xia Y. F., Tong B., Zhang C. F., Pan R. and Xu H., et al. (2014). In vitro anti-angiogenesis effects and active constituents of the saponin fraction from Gleditsia sinensis. Integrative Cancer Therapies, 13 (5): 446-457. |
[22] | Kato K., Kaihou S., Hagiwara S. Y., Tomiyama T. and Hamada H. (2005). A novel antitumor effect of water extract from Pleurotus cornucopia that promotes dendritic cell activation and down-regulation of regulatory T cells in tumor-bearing mice. AACR Meeting Abstracts, 2005: 172. |
[23] | Wu D. Y., Pae M., Ren Z. H., Guo Z. Y., Smith D. and Meydani S. N. (2007). Dietary supplementation with white button mushroom enhances natural killer cell activity in C57BL/6 Mice. The Journal of nutrition, 137: 1472-1477. |
APA Style
Zhang Shuhong, Zhang Yunfeng, Gao Fengju, Fan Yongshan. (2022). Dose-Dependent and Time-Dependent Antitumor Activity of Pleurotus ostreatus Polysaccharides in Vitro. American Journal of BioScience, 10(2), 75-80. https://doi.org/10.11648/j.ajbio.20221002.16
ACS Style
Zhang Shuhong; Zhang Yunfeng; Gao Fengju; Fan Yongshan. Dose-Dependent and Time-Dependent Antitumor Activity of Pleurotus ostreatus Polysaccharides in Vitro. Am. J. BioScience 2022, 10(2), 75-80. doi: 10.11648/j.ajbio.20221002.16
AMA Style
Zhang Shuhong, Zhang Yunfeng, Gao Fengju, Fan Yongshan. Dose-Dependent and Time-Dependent Antitumor Activity of Pleurotus ostreatus Polysaccharides in Vitro. Am J BioScience. 2022;10(2):75-80. doi: 10.11648/j.ajbio.20221002.16
@article{10.11648/j.ajbio.20221002.16, author = {Zhang Shuhong and Zhang Yunfeng and Gao Fengju and Fan Yongshan}, title = {Dose-Dependent and Time-Dependent Antitumor Activity of Pleurotus ostreatus Polysaccharides in Vitro}, journal = {American Journal of BioScience}, volume = {10}, number = {2}, pages = {75-80}, doi = {10.11648/j.ajbio.20221002.16}, url = {https://doi.org/10.11648/j.ajbio.20221002.16}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajbio.20221002.16}, abstract = {Elucidation of the in vitro antitumor effects of Pleurotus ostreatus polysaccharides is very important for their future clinical application. In this paper, we use Sarcoma-180 (S180) cells to test the antitumor activity of the mushroom polysaccharides. The S180 cells in freshly prepared mouse ascites were directly treated by water-soluble polysaccharides from mycelium of Pleurotus ostreatus and immediately detected by MTT [3-(4,5)-dimethylthiahiazo (-z-y1)-3,5-di- phenytetrazoliumromide] method. The results can be directly visualized with naked eyes through the color changes. The in vitro antitumor activity of P. ostreatus polysaccharides on S180 cells are dose-dependently and time-dependently. P. ostreatus strains p11, p23, P44, p105 and p176 showed significant inhibition to S180 cell activity under high polysaccharides concentration (1000μg/ml ~ 1250μg/ml), and there are non-significant effects under the middle concentration (750μg/ml). On the contrary, the S180 cell activity were significantly enhanced under low concentration (250μg/mL-500μg/ml). The effects of polysaccharides generally increased during 4-8 treat hours, but remained stable more than 7 hours. However, the strains P23, P44 and P105 enhanced the S180 cell activity for short time processing (4-5h), but inhibited the cell activity for long time processing (6-8h). Among the tested mushroom strains, P44 exhibited the highest inhibition rate (68.4%) under high concentration of 1250µg/ml and treat time of 7-8 hours, P23 had the highest enhancement (119.5%) under low concentration of 250µg/ml and treat time of 8 hours. The antitumor activity of P. ostreatus polysaccharides was dependent on its concentration and treat time, indicating the complicated antitumor mechanism of mushroom polysaccharides and the strict study should be conducted before their clinical application.}, year = {2022} }
TY - JOUR T1 - Dose-Dependent and Time-Dependent Antitumor Activity of Pleurotus ostreatus Polysaccharides in Vitro AU - Zhang Shuhong AU - Zhang Yunfeng AU - Gao Fengju AU - Fan Yongshan Y1 - 2022/04/20 PY - 2022 N1 - https://doi.org/10.11648/j.ajbio.20221002.16 DO - 10.11648/j.ajbio.20221002.16 T2 - American Journal of BioScience JF - American Journal of BioScience JO - American Journal of BioScience SP - 75 EP - 80 PB - Science Publishing Group SN - 2330-0167 UR - https://doi.org/10.11648/j.ajbio.20221002.16 AB - Elucidation of the in vitro antitumor effects of Pleurotus ostreatus polysaccharides is very important for their future clinical application. In this paper, we use Sarcoma-180 (S180) cells to test the antitumor activity of the mushroom polysaccharides. The S180 cells in freshly prepared mouse ascites were directly treated by water-soluble polysaccharides from mycelium of Pleurotus ostreatus and immediately detected by MTT [3-(4,5)-dimethylthiahiazo (-z-y1)-3,5-di- phenytetrazoliumromide] method. The results can be directly visualized with naked eyes through the color changes. The in vitro antitumor activity of P. ostreatus polysaccharides on S180 cells are dose-dependently and time-dependently. P. ostreatus strains p11, p23, P44, p105 and p176 showed significant inhibition to S180 cell activity under high polysaccharides concentration (1000μg/ml ~ 1250μg/ml), and there are non-significant effects under the middle concentration (750μg/ml). On the contrary, the S180 cell activity were significantly enhanced under low concentration (250μg/mL-500μg/ml). The effects of polysaccharides generally increased during 4-8 treat hours, but remained stable more than 7 hours. However, the strains P23, P44 and P105 enhanced the S180 cell activity for short time processing (4-5h), but inhibited the cell activity for long time processing (6-8h). Among the tested mushroom strains, P44 exhibited the highest inhibition rate (68.4%) under high concentration of 1250µg/ml and treat time of 7-8 hours, P23 had the highest enhancement (119.5%) under low concentration of 250µg/ml and treat time of 8 hours. The antitumor activity of P. ostreatus polysaccharides was dependent on its concentration and treat time, indicating the complicated antitumor mechanism of mushroom polysaccharides and the strict study should be conducted before their clinical application. VL - 10 IS - 2 ER -